| Trial ID: | L0161 |
| Source ID: | NCT02863185
|
| Associated Drug: |
Pitavastatin
|
| Title: |
Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Pitavastatin|DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: mean difference and change of erythrocyte membrane fatty acid including oleic acid, baseline and 24 weeks after intervention | Secondary: mean difference and change of total cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol, baseline and 24 weeks after intervention|mean difference and change of adiponectin, baseline and 24 weeks after intervention|mean difference and change of glucose and glycosylated hemoglobin, baseline and 24 weeks after intervention|mean difference and change of proteinuria, baseline and 24 weeks after intervention
|
| Sponsor/Collaborators: |
Sponsor: Dong-A University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
45
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-05-01
|
| Completion Date: |
2020-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2021-09-21
|
| Locations: |
Won Suk An, Busan, 602-715, Korea, Republic of|Dong-A University, Busan, 602715, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02863185
|
